METROPOLITAN LIFE INSURANCE CO/NY - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 107 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$19,834
-35.1%
5,1250.0%0.00%0.0%
Q2 2023$30,545
+190.3%
5,125
+59.3%
0.00%0.0%
Q1 2023$10,523
-53.6%
3,218
-44.0%
0.00%0.0%
Q4 2022$22,685
-34.2%
5,7430.0%0.00%
-50.0%
Q3 2022$34,458
-6.7%
5,7430.0%0.00%0.0%
Q2 2022$36,927
-22.2%
5,7430.0%0.00%0.0%
Q1 2022$47,437
-86.8%
5,743
-75.3%
0.00%
-60.0%
Q4 2021$360,467
-31.3%
23,2860.0%0.01%
-37.5%
Q3 2021$524,401
+200.7%
23,286
+162.5%
0.01%
+300.0%
Q2 2021$174,384
+237.2%
8,870
+474.1%
0.00%
+100.0%
Q1 2021$51,7111,5450.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders